These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 138262)
21. Clinical evaluation of ketoprofen (Orudis) in rheumatoid arthritis. Results of a multi-centre, double-blind, cross-over trial against phenylbutazone. Sydnes O; Brath HK; Haerum LB; Straume S Scand J Rheumatol Suppl; 1976; 1976(0):119-22. PubMed ID: 790547 [TBL] [Abstract][Full Text] [Related]
22. [Treatment of rheumatic diseases with a new antirheumatism drug: isopyrine hydrochloride and phebuzine]. Debes AC; Federico W; Spilborghs G Rev Bras Med; 1965 Jul; 22(7):443-4. PubMed ID: 5321989 [No Abstract] [Full Text] [Related]
23. [Meprotixol (N 7020). Clinical experiences in rheumatic diseases]. Kogstad O Tidsskr Nor Laegeforen; 1974 Feb; 94(4):212-4. PubMed ID: 4595469 [No Abstract] [Full Text] [Related]
25. [The association of paracetamol and phenylbutazone in rheumatology. Preliminary report]. Wettreich W Hospital (Rio J); 1966 Aug; 70(2):427-32. PubMed ID: 5300316 [No Abstract] [Full Text] [Related]
26. [Meprotixol (N 7020). Studied in rheumatic diseases in a double blind multicenter investigation in general practice]. Kogstad O; Apall-Olsen P; Fjerdingstad S; Garfelt R; Helgesen RO; Joheim I; Klaastad R; Rosenberg I; Selvåg J; Toreid K; Tonnessen JS Tidsskr Nor Laegeforen; 1974 Feb; 94(4):209-12. PubMed ID: 4595468 [No Abstract] [Full Text] [Related]
27. [Effectiveness and pharmacological effect of a new non-steroid drug tosiben in the treatment of rheumatic diseases]. Matulis AA; Kurtinite GP; Mishkinite GA; Vidugirene RIu; Vil'dzhiunene BE Ter Arkh; 1978; 50(9):21-6. PubMed ID: 705647 [No Abstract] [Full Text] [Related]
28. [Therapeutic use of clofezone in rheumatic diseases]. Vitaus M; Franovic A; Dürrigl T Schweiz Rundsch Med Prax; 1973 Jan; 62(3):78-82. PubMed ID: 4282506 [No Abstract] [Full Text] [Related]
29. A comparative, double-blind study on tolfenamic acid in the treatment of rheumatoid arthritis. Rejholec V; Vapaatalo H; Tokola O; Gothoni G Scand J Rheumatol Suppl; 1979; (24):13-6. PubMed ID: 373084 [TBL] [Abstract][Full Text] [Related]
30. [Our 1st experiences with tanderil in the treatment of rheumatic diseases]. Vitaus M Reumatizam; 1966; 13(6):216-7. PubMed ID: 5973924 [No Abstract] [Full Text] [Related]
31. [Comparative studies on the bioavailability of various drug forms of phenylbutazone and clofezone (Perclusone)]. Reinicke C; Helbing M; Klingenfeld U; Lasaroff I; Wessel G Pharmazie; 1984 Dec; 39(12):824-7. PubMed ID: 6241720 [TBL] [Abstract][Full Text] [Related]
32. [On the treatment of rheumatic diseases with Delta-Tomanol]. Wille T Ther Ggw; 1968 Nov; 107(11):1512-4 passim. PubMed ID: 5306056 [No Abstract] [Full Text] [Related]
33. [What can we expect from an anti-inflammatory agent after 3 years of experimentation and rheumatologic practice?]. Weissenbach R Therapeutique; 1972 Dec; 48(10):685-8. PubMed ID: 4540974 [No Abstract] [Full Text] [Related]
34. [Treatment of acute uric arthritis using Perclusone]. Cunović S Reumatizam; 1973; 20(4):156-9. PubMed ID: 4731458 [No Abstract] [Full Text] [Related]
35. [Experience with a combination of phenylbutazone, isopyrin and prednisolone in the treatment of rheumatoid arthritis]. Rau R Med Welt; 1969 Sep; 36():1976-81. PubMed ID: 5809876 [No Abstract] [Full Text] [Related]